Targeting the <scp>ABCG</scp>2‐overexpressing multidrug resistant (<scp>MDR</scp>) cancer cells by <scp>PPAR</scp>γ agonists
Kenneth K.W. To(Chinese University of Hong Kong), Brian Tomlinson(Chinese University of Hong Kong)
Cited by 35
Related Papers
MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside
|World Journal of Gastroenterology|2018|205
Suppression of Hypoxia-inducible Factor 1α (HIF-1α) Transcriptional Activity by the HIF Prolyl Hydroxylase EGLN1
|Journal of Biological Chemistry|2005|113
Effect of Extended-Release Niacin/Laropiprant Combination on Plasma Adiponectin and Insulin Resistance in Chinese Patients with Dyslipidaemia
|Disease Markers|2015|10
A platinum-based hybrid drug design approach to circumvent acquired resistance to molecular targeted tyrosine kinase inhibitors
|Scientific Reports|2016|10
Circumvention of Gefitinib Resistance by Repurposing Flunarizine via Histone Deacetylase Inhibition
|ACS Pharmacology & Translational Science|2023|8